Personal finance
Burger King slims down for success
The Penguin-Random House merger: 3 takeaways
Dunkin' weathers storm to attract crowds
Inside Wall Street: Bank weathers its own storm
How Sandy will affect shipping business
The whopping US rally that wasn't
Disney acquires Lucasfilm for $4B
Late-inning earnings plays
Gilead's 'son of Viread' passes first test
Auto sales expected to stay strong into 2013
Why Yamana shares are soaring
Archer Daniels Midland is boring and cheap
Stericycle finds treasure in trash
Don't follow Icahn into Netflix
How to trade the US presidential election
David Einhorn is shorting iron ore
What's next for Exxon after Rosneft buy?
Who's right, Main Street or Wall Street?
Hershey shareholders sue for child labor records
China's growth picks up
Europe offsets Johnson Controls' Asia gains
CSX took too heavy a beating
In retail, pessimism doesn't pay
Illumina should reconsider Roche's offer
4 Canadian value stocks
I believe many outstanding buying opportunities exist among undervalued Canadian stocks. Canada's banks were not allowed to sell risky loans, its housing market remains solid, its economic growth continues to climb, and its debt remains low.

I screened my Ben Graham Database to find Canadian companies with rapidly growing earnings and strong balance sheets. The four stocks below offer excellent appreciation potential during the next six to 12 months.

Agrium (AGU -0.54%)
Based in Calgary, Agrium is a leading producer, wholesaler and retailer of agricultural nutrients and industrial products in North and South America. Products include nitrogen, phosphate and potash fertilizers; herbicides, insecticides and fungicides; and seeds.

Nitrogen fertilizers account for 37% of Agrium's wholesale business and are enjoying increased profits because of the low price of natural gas, which is used as an ingredient in the manufacturing process.

Demand is rising for crop protection products in North America, and potash exports to Brazil and China are increasing. High crop prices in the U.S. and elsewhere will enable farmers to use more nutrients to increase crop production.

In addition, worldwide population growth will spur demand for increased farm production and improved efficiency which can be provided by better nutrients and crop protection. Sales increased 15% and EPS advanced 20% during the past 12 months ended 9/30/12.

The semi-annual dividend was increased to $0.50 from $0.055 a year ago, and now provides a yield of 1.0%. After a slow year ahead, future earnings growth will be erratic but should average 15% per year.

Bank of Montreal (BMO +0.54%)
Founded in 1817 in Montreal, Bank of Montreal provides a wide range of retail banking, wealth management and investment banking services in North America. The bank also provides an array of credit and non-credit products and services.

The bank maintains 1,600 bank branches in Canada and the U.S., and operates internationally in major financial markets and trading areas throughout most of the world.

Bank of Montreal has made three major acquisitions during the past three years. Marshall & Ilsley (M&I) of Wisconsin was purchased in July 2011 for $4.2 billion. BMO paid a very reasonable price, but M&I's loan portfolio includes some non-performing loans.

BMO folded M&I Bank into its Harris Bank division (based in Chicago). In 2009, BMO acquired Diners Club North America from Citigroup for $1.0 billion cash. In 2009, it acquired AIG's Canadian Life and Health Insurance unit for $375 million cash.

Revenues climbed 22% and earnings per share (EPS) increased 13% during the 12 months ended Sept. 30. Remarkably, Bank of Montreal has been paying dividends since 1829. It now provides a high 4.8% yield. At 9.7 times my forward 12-month EPS forecast of $6.16, the shares are undervalued. BMO is low risk.

Gildan Activewear (GIL +0.25%)
Gildan, based in Montreal, manufactures basic apparel including T-shirts, sport shirts, socks and sweat clothes. It sells plain garments, known as blanks, to screenprinters and decorators who add designs and logos.

The company is adding new products, including men's and boy's underwear, and expanding geographically into Mexico and Asia. The company has steadily boosted its U.S. market share for major items, partly because of the low price of its products.

Gildan suffered through a year of very high cotton prices which caused expenses to soar and profits to drop. Cotton prices have retreated to previous levels during recent months. Profits will probably rebound 82% during the 12-month period ending 9/30/13 from the depressed EPS level during the last 12 months.

GIL shares remain undervalued at 13.7 times my 12-month forward EPS estimate of 2.35 despite the probable surge in sales and earnings during the foreseeable future.

Valeant Pharmaceuticals International (VRX +0.21%)
Based in Mississauga, near Toronto, Valeant markets about 900 pharmaceutical products globally. It has developed drugs in almost all areas of medicine with a slightly higher emphasis on neurology and dermatology products.

The 2010 merger with Biovail tripled Valeant's sales. The marriage has produced better-than-expectedr03; results and includes a vast array of products and marketing capabilities throughout the world.

Management is aggressively acquiring small companies with potential to immediately add earnings (commonly called accretive). It has acquired 50 companies during the past four years.

The pharma recently announced its biggest deal since the merger with Biovail, the acquisition of Medicis Pharmaceutical for $2.4 billion. The purchase is due to be completed during the first or second quarter of 2013 and will be immediately accretive to Valeant's earnings.

For now, the price-to-earnings ratio of 11.6 is a bargain, even though the company pays no dividend. The balance sheet is solid, although debt is a tad high. VRX is high risk because of the stock's high volatility and the company's erratic past performance.

Для печати
Microsoft will 'die and disappear' in next few years
Whole Foods' freshness starting to wilt
In a war of attrition, Microsoft will beat Apple again
Asbury Automotive sees strong earnings momentum
Student debtors get the runaround
What to keep in your money survival kit
First-date coupon use is on the rise
Groupon offers NYC dinner in the dark
The worst credit cards of 2012
Post-Sandy, banks waive fees
Homeowners spared costly hurricane deductible
7 ways to commit financial suicide
Why are car loans so easy to get?
Best credit cards after bankruptcy
Get more cash for your old clothes
5 fee-free ways to help Sandy victims
After a flood, frugality can be dangerous
After the storm: Rebuild or move?
My unexpected $2,400 vet bill
Best credit cards for holiday shopping
Downside of a higher retirement age
Prepaid cards are not gift cards
Is the economy destroying love?
Financial lesson from a football game
Book Christmas flights before Black Friday
6 ways to earn extra holiday cash
Holiday shopping? Avoid this retail trick
Many holding out for Cyber Monday
SiriusXM drives straight race to $3 a share
Sandy: Beware the bubble in storm stocks
Starbucks: Buy it, own it, love it
4 Canadian value stocks
What's the White House worth?
Stocks are immune to Washington
EMC strengthens RSA business with acquisition
Russia garners another favorable valuation call
Goldman Sachs slashes partnership ranks
Inside Wall Street: Cheers from Bud and Diageo
4 favorites for a housing rebound
Is Baidu's China reign over?
In 2013, Apple, Facebook will fly, Intel will die
Is AOL's turnaround for real?
Stock buyback blitz continues
Anheuser-Busch pushes higher-alcohol beers
Baidu: Searching for growth in China
Twitter vs. Facebook: The war heats up
Would Disney buy Hasbro?
Vending-machine pizza prepares for US debut
Amazon lockers coming to Staples
Are customers becoming less loyal to Apple?
Focus on earnings, not fiscal cliff
Evergreen stocks: 4 favorite dividend ideas
Visit Statistics